Adage Capital Partners Portfolio holdings
AUM
$59.3B
This Quarter Return
+27.25%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$39.1B
AUM Growth
+$39.1B
(+17%)
Cap. Flow
-$1.07B
Cap. Flow
% of AUM
-2.74%
Top 10 Holdings %
Top 10 Hldgs %
25.2%
Holding
834
New
111
Increased
264
Reduced
307
Closed
110
Top Buys
| 1 |
Royalty Pharma
RPRX
|
$2.23B |
| 2 |
Otis Worldwide
OTIS
|
$211M |
| 3 |
Burlington
BURL
|
$200M |
| 4 |
AbbVie
ABBV
|
$199M |
| 5 |
Wayfair
W
|
$190M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$1.66B |
| 2 |
Lockheed Martin
LMT
|
$327M |
| 3 |
Johnson & Johnson
JNJ
|
$253M |
| 4 |
Pfizer
PFE
|
$153M |
| 5 |
Target
TGT
|
$148M |
Sector Composition
| 1 | Technology | 21.53% |
| 2 | Healthcare | 19.78% |
| 3 | Consumer Discretionary | 13.1% |
| 4 | Financials | 11.32% |
| 5 | Industrials | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Otis Worldwide
OTIS
$33.9B
| $211M | 0.54% | +3,716,333 | New | +$211M |
|
27
Bank of America
BAC
$376B
| $208M | 0.53% | 8,744,386 +841,500 | +11% | +$20M |
|
28
Fortive
FTV
$16.2B
| $205M | 0.53% | 3,033,305 +1,800,793 | +146% | +$122M |
|
29
AT&T
T
$209B
| $204M | 0.52% | 6,752,758 +1,974,700 | +41% | +$59.7M |
|
30
Exxon Mobil
XOM
$487B
| $202M | 0.52% | 4,519,192 +704,300 | +18% | +$31.5M |
|
31
Coca-Cola
KO
$297B
| $199M | 0.51% | 4,454,482 +32,000 | +0.7% | +$1.43M |
|
|
32
AbbVie
ABBV
$372B
| $199M | 0.51% | +2,022,311 | New | +$199M |
|
33
Amgen
AMGN
$155B
| $197M | 0.5% | 833,572 +213,700 | +34% | +$50.4M |
|
34
Walmart
WMT
$774B
| $193M | 0.49% | 1,613,345 -456,396 | -22% | -$54.7M |
|
35
Lowe's Companies
LOW
$145B
| $191M | 0.49% | 1,412,860 +388,917 | +38% | +$52.6M |
|
|
36
Wayfair
W
$9.67B
| $190M | 0.49% | +960,000 | New | +$190M |
|
37
Salesforce
CRM
$245B
| $186M | 0.48% | 991,023 -22,200 | -2% | -$4.16M |
|
38
Citigroup
C
$178B
| $182M | 0.47% | 3,553,988 -250,300 | -7% | -$12.8M |
|
|
HZNP
39
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $181M | 0.46% | +3,255,949 | New | +$181M |
|
40
Verizon
VZ
$186B
| $180M | 0.46% | 3,267,802 -2,125,500 | -39% | -$117M |
|
41
Abbott
ABT
$231B
| $178M | 0.46% | 1,945,952 -79,826 | -4% | -$7.3M |
|
42
Sarepta Therapeutics
SRPT
$1.78B
| $176M | 0.45% | 1,100,000 -925,000 | -46% | -$148M |
|
43
RTX Corp
RTX
$212B
| $173M | 0.44% | 2,810,280 +1,595,426 | +131% | +$98.3M |
|
44
Merck
MRK
$210B
| $173M | 0.44% | 2,233,206 -594,700 | -21% | -$46M |
|
45
Thermo Fisher Scientific
TMO
$186B
| $166M | 0.42% | 457,289 -107,200 | -19% | -$38.8M |
|
46
Accenture
ACN
$162B
| $159M | 0.41% | 740,300 +5,800 | +0.8% | +$1.25M |
|
47
McDonald's
MCD
$224B
| $159M | 0.41% | 861,415 +14,081 | +2% | +$2.6M |
|
48
Fidelity National Information Services
FIS
$36.5B
| $154M | 0.39% | 1,145,750 -341,800 | -23% | -$45.8M |
|
49
Comcast
CMCSA
$125B
| $147M | 0.38% | 3,764,295 -409,061 | -10% | -$15.9M |
|
50
Qualcomm
QCOM
$173B
| $144M | 0.37% | 1,582,160 +347,396 | +28% | +$31.7M |
|